New device aims to ease glaucoma pressure in early trial

NCT ID NCT07358650

Recruiting now Disease control Sponsor: Hexiris Inc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new tool called the MIST device to lower eye pressure in people with primary open-angle glaucoma. About 25 adults aged 40 and older whose eye pressure is not well controlled with eye drops will receive the procedure. Researchers will check how safe the device is and how well it works over 12 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY OPEN ANGLE GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRIMARY OPEN ANGLE GLAUCOMA

Contacts and locations

Locations

Eye Care Centre NB
RECRUITING

Dieppe, New Brunswick, E1A 9T8, Canada
Institut de l'oeil des Laurentides
RECRUITING

Boisbriand, Quebec, J7H 0E8, Canada
Miramichi EyeNB & Surgical Centres of Excellence
RECRUITING

Miramichi, New Brunswick, E1N 1B2, Canada
Ophthalmology Clinic Bellevue
RECRUITING

Montreal, Quebec, H1V 1G5, Canada
Prism Eye Institute Inc.
RECRUITING

Brampton, Ontario, L6Y 4M3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.